Breaking News Instant updates and real-time market news.

KO

Coca-Cola

$51.25

-0.15 (-0.29%)

, UTX

United Technologies

$132.94

0.57 (0.43%)

20:25
07/22/19
07/22
20:25
07/22/19
20:25

Notable companies reporting before tomorrow's open

Notable companies reporting before tomorrow's open, with earnings consensus, include Coca-Cola (KO), consensus 61c... United Technologies (UTX), consensus $2.04... Lockheed Martin (LMT), consensus $4.77... Kimberly-Clark (KMB), consensus $1.61... Biogen (BIIB), consensus $7.32... Sherwin-Williams (SHW), consensus $6.36... Travelers (TRV), consensus $2.29... PACCAR (PCAR), consensus $1.81... Centene (CNC), consensus $1.23... Stanley Black & Decker (SWK), consensus $2.55... Fifth Third Bancorp (FITB), consensus 66c... KeyCorp (KEY), consensus 44c... TransUnion (TRU), consensus 65c... Hasbro (HAS), consensus 50c... Quest Diagnostics (DGX), consensus $1.68... Lamb Weston (LW), consensus 72c... JetBlue Airways (JBLU), consensus 57c... Harley-Davidson (HOG), consensus $1.20... Medidata Solutions (MDSO), consensus 39c... Graphic Packaging (GPK), consensus 21c... AutoNation (AN), consensus $1.06.

KO

Coca-Cola

$51.25

-0.15 (-0.29%)

UTX

United Technologies

$132.94

0.57 (0.43%)

LMT

Lockheed Martin

$357.57

0.675 (0.19%)

KMB

Kimberly-Clark

$134.40

-1.31 (-0.97%)

BIIB

Biogen

$232.46

1.26 (0.54%)

SHW

Sherwin-Williams

$454.62

-1.9 (-0.42%)

TRV

Travelers

$149.95

-0.22 (-0.15%)

PCAR

Paccar

$69.17

-0.16 (-0.23%)

CNC

Centene

$52.19

-0.46 (-0.87%)

SWK

Stanley Black & Decker

$141.45

-2.01 (-1.40%)

FITB

Fifth Third

$27.84

-0.11 (-0.39%)

KEY

KeyCorp

$17.37

-0.08 (-0.46%)

TRU

TransUnion

$74.91

-0.14 (-0.19%)

HAS

Hasbro

$108.54

0.85 (0.79%)

DGX

Quest Diagnostics

$98.07

-1.175 (-1.18%)

LW

Lamb Weston

$67.58

-0.98 (-1.43%)

JBLU

JetBlue

$18.96

0.05 (0.26%)

HOG

Harley-Davidson

$34.25

-0.62 (-1.78%)

MDSO

Medidata

$90.93

0.2 (0.22%)

GPK

Graphic Packaging

$14.27

0.025 (0.18%)

AN

AutoNation

$42.01

-0.045 (-0.11%)

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 01

    Aug

  • 01

    Aug

  • 06

    Aug

  • 06

    Aug

  • 08

    Aug

  • 12

    Aug

  • 29

    Aug

  • 09

    Sep

  • 19

    Sep

  • 13

    Nov

KO Coca-Cola
$51.25

-0.15 (-0.29%)

06/04/19
MSCO
06/04/19
NO CHANGE
MSCO
Morgan Stanley suggests pair trade of long Coca-Cola, short Keurig Dr Pepper
Morgan Stanley analyst Dara Mohsenian is suggesting a pair trade of being Overweight Coca-Cola (KO) and Underweight Keurig Dr Pepper (KDP), citing his view that Coke has "much higher" growth potential and Keurig has "much greater" risk even though both stocks trade at similar 2021 EV/EBITDA valuations. Mohsenian contends this mispricing of two companies in the same sector is the greatest he has seen since December 2015 when he made a call to favor Estee Lauder (EL) over Coty (COTY), the analyst noted. Mohsenian has a $55 price target on shares of Coca-Cola and a $24 price target on Keurig.
05/14/19
ARGS
05/14/19
NO CHANGE
ARGS
Hold
Argus looking for 'favorable entry point' in Coca-Cola
Argus analyst Chris Graja kept his Hold rating on Coca-Cola, but says that he is looking for a "favorable entry point" on the stock and would "strongly consider" an upgrade to his rating at a price of $40-$42 per share. The analyst sees the company as "reasonably valued" based on his projected 8% earnings growth rate as well as his view of Coca-Cola's financial strength and ability to deploy cash.
05/14/19
05/14/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Tyson Foods (TSN) upgraded to Outperform from Neutral at Credit Suisse and to Buy from Hold at Argus. 2. Coca-Cola (KO) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Dara Mohsenian saying the company's growth outlook is "clearly superior" relative to the packaged goods space, but this is not reflected in the current share price. 3. Capital One (COF) upgraded to Buy from Hold at Jefferies with analyst John Hecht saying he expects the stock to benefit from "bigger payouts and improving efficiencies." 4. Deckers Brands (DECK) upgraded to Positive from Neutral at Susquehanna. 5. Agco (AGCO) upgraded to Overweight from Neutral at JPMorgan with analyst Ann Duignan saying given Agco's limited exposure to the U.S. row crop sector, the recent sell-off in the shares is overdone. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/22/19
GUGG
05/22/19
NO CHANGE
Target $103
GUGG
Buy
AB InBev named a sector Best Idea, replacing Coca-Cola at Guggenheim
Guggenheim analyst Laurent Grandet named Anheuser-Busch InBev (BUD) his sector Best Idea, replacing Coca-Cola (KO), citing his increased conviction in its U.S. growth following an investor seminar hosted by the company. The analyst, who also sees untapped "premiumization" opportunities and significant potential in emerging markets, raised his FY19, FY20 and FY21 EPS estimates for AB InBev but keeps an unchanged price target of $103 on the stock with a Buy rating.
UTX United Technologies
$132.94

0.57 (0.43%)

07/08/19
JPMS
07/08/19
DOWNGRADE
Target $231
JPMS
Underweight
JPMorgan's Tusa downgrades Lennox to Underweight with $231 price target
JPMorgan analyst Stephen Tusa downgraded Lennox International (LII) to Underweight from Neutral with an unchanged price target of $231. The analyst this morning also upgraded Johnson Controls (JCI) to Neutral from Underweight. Lennox's standing premium to implied HVAC multiples "at soon to be pure play peers seems overdone," Tusa tells investors in a research note. The analyst believes the emergence of two new pure plays, "seemingly currently trading at ~30% discounts," dilutes Lennox's scarcity value. Tusa's price target implies 20% downside versus his Overweight-rated HVAC related names, Ingersoll-Rand (IR) and United Technologies (UTX).
06/24/19
06/24/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. United Technologies (UTX) upgraded to Outperform from Market Perform at Cowen with analyst Cai von Rumohr citing the selloff in the shares after the Raytheon (RTN) merger announcement. 2. Deere (DE) and Agco (AGCO) upgraded to Buy from Hold at Jefferies. 3. Rent-A-Center (RCII) upgraded to Equal Weight from Underweight at Stephens with analyst Vincent Caintic citing what he sees as "massive potential" for third-party retailer Rent-To-Own, telling investors that he wouldn't want to be short any Rent-To-Own stock he covers as a result. 4. Hostess Brands (TWNK) upgraded to Buy from Neutral at UBS with Steven Strycula citing three catalysts he sees. 5. Dunkin' Brands (DNKN) upgraded to Outperform from Neutral at Wedbush with analyst Nick Steyan saying he believes Dunkin' U.S. is currently undergoing an inflection in same-store sales growth that is underappreciated by the Street. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/24/19
06/24/19
DOWNGRADE

Neutral
Raytheon downgraded to Neutral from Buy at Buckingham
As previously reported, Buckingham analyst Richard Safran downgraded Raytheon (RTN) to Neutral from Buy and lowered his price target on the shares to $195 from $265. The analyst said that initially he was neutral on the deal with United Technologies (UTX), which Buckingham does not cover, but now believes it is a solid deal for United Technologies that "possibly undervalues" Raytheon. Safran added that until the deal is either completed or denied by the Pentagon, Raytheon shares will now be tied to United Technologies.
06/24/19
06/24/19
UPGRADE

Outperform
United Technologies upgraded to Outperform from Market Perform at Cowen
As previously reported, Cowen analyst Cai von Rumohr upgraded United Technologies (UTX) to Outperform from Market Perform following the selloff in the shares after the Raytheon (RTN) merger announcement. The analyst raised his price target on United Technologies shares to $150 from $135. The analyst was positive on the "attractive" proposed Raytheon merger, seeing synergies in hypersonics, directed energy, ISR, cyber protection for connected aircraft, and air traffic control. The analyst also liked United Technologies for the "extended Aerospace cash ramp," as they see a likely multiyear margin/cash flow ramp in that space.
LMT Lockheed Martin
$357.57

0.675 (0.19%)

01/10/19
01/10/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Constellation Brands (STZ) upgraded to Buy from Neutral at Goldman Sachs and to Neutral from Sell at Guggenheim. 2. Boeing (BA) upgraded to Overweight from Equal Weight at Morgan Stanley. 3. Lockheed Martin (LMT) upgraded to Buy from Hold at Vertical Group. 4. United Continental (UAL) upgraded to Overweight from Neutral at JPMorgan while Alaska Air (ALK) was upgraded to Neutral from Underweight. 5. Twitter (TWTR) double upgraded to Buy from Underperform at BofA/Merrill with analyst Justin Post citing a survey he conducted which showed Twitter penetration increased to 48% of respondents and the percentage of users reporting deceased usage fell slightly. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/10/19
01/10/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Lockheed Martin (LMT) downgraded to Equal Weight from Overweight at Morgan Stanley. 2. JetBlue (JBLU) downgraded to Neutral from Overweight at JPMorgan with analyst Jamie Baker lowering his price target for the shares to $18 from $20. 3. Weatherford (WFT) downgraded to Market Perform from Outperform at BMO Capital with analyst Daniel Boyd saying the stock represents a "call-option on the oil cycle," but sees that option "suffering from time decay" and an adverse macro environment. 4. Yelp (YELP) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Brian Nowak saying he identified three building revenue headwinds that he believes will lead to negative revisions and underperformance of the stock. 5. Dollar Tree (DLTR) downgraded to Perform from Outperform at Oppenheimer with analyst Rupesh Parikh saying he now views shares as fully valued and sees the case for upside as less attractive. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/10/19
01/10/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Ship Finance (SFL) initiated with a Neutral at B. Riley FBR. 2. Wipro (WIT) initiated with a Hold at Deutsche Bank. 3. Boeing (BA), Lockheed Martin (LMT), and Raytheon (RTN) were initiated with a Positive at Susquehanna while Northrop Grumman (NOC) and General Dynamics (GD) were initiated with a Neutral. 4. Dollar General (DG) initiated with an Outperform at BMO Capital while Dollar Tree (DLTR) was initiated with a Market Perform. 5. Verint (VRNT) initiated with a Buy at Jefferies. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/16/19
ARGS
05/16/19
NO CHANGE
Target $82
ARGS
Buy
Leidos price target raised to $82 from $70 at Argus
Argus analyst John Eade raised his price target on Leidos (LDOS) to $82 and kept his Buy rating after its recent Q1 earnings beat. The analyst believes that the company's revenue growth could pick up given the "positive bookings trends" as well as a favorable political backdrop for defense companies with budgets for this year being set at record levels. Eade adds that his view of the company's merger with Lockheed Martin's (LMT) Information Systems & Global Solutions unit is a positive.
KMB Kimberly-Clark
$134.40

-1.31 (-0.97%)

04/23/19
04/23/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Qualcomm (QCOM) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst James Faucette citing his view that the market has "not yet fully appreciated" the impact of the company's settlement with Apple (AAPL), which he thinks not only increases earnings substantially while also expanding the freedom with which Qualcomm can pursue new opportunities. 2. Kimberly-Clark (KMB) upgraded to Buy from Hold at Argus and to Outperform from Neutral at Macquarie. 3. Sanderson Farms (SAFM) upgraded to Neutral from Sell at Goldman Sachs with analyst Adam Samuelson saying African swine fever is upending the protein markets, Samuelson tells investors in a research note. 4. Visteon (VC) upgraded to Outperform from Neutral at Baird while Veoneer (VNE) was upgraded to Neutral from Underperform. 5. Sony (SNE) upgraded to Outperform from Neutral at Macquarie. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/23/19
ARGS
04/23/19
UPGRADE
ARGS
Buy
Kimberly-Clark upgraded to Buy from Hold at Argus
04/23/19
MACQ
04/23/19
UPGRADE
MACQ
Outperform
Kimberly-Clark upgraded to Outperform from Neutral at Macquarie
06/18/19
MSCO
06/18/19
NO CHANGE
Target $145
MSCO
Equal Weight
Morgan Stanley sees near-term upside in Kimberly-Clark from better input costs
The substantial decline in pulp prices recently, along with elevated pulp inventory levels, has materially changed Kimberly-Clark's input cost inflation outlook, according to Morgan Stanley analyst Dara Mohsenian. Given that the better input costs should drive near-term EPS upside, he is making a positive short-term trading call in the stock, predicting that the company will cut its input cost inflation guidance by $75M to $225-$325M and raise its FY19 EPS guidance to $6.60-6.80 from $6.50-6.70. Though Mohsenian raised his price target on Kimberly-Clark shares to $145 from $132, he keeps an Equal Weight rating on the stock on a longer-term view, as he still expects market share struggles and sees lower growth potential.
BIIB Biogen
$232.46

1.26 (0.54%)

06/28/19
PIPR
06/28/19
DOWNGRADE
Target $250
PIPR
Neutral
Biogen downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Christopher Raymond downgraded Biogen (BIIB) to Neutral from Overweight and lowered his price target for the shares to $250 from $280. The stock closed yesterday up $1.70 to $239.77. Piper's new neurologist survey data from Spherix Global Insights "spells bad news for both Tecfidera and Tysabri in the near and longer term," Raymond tells investors in a research note. For the first time in a long time, Tecfidera market share is projected to contract over the next six months, primarily at the hands of Novartis' (NVS) new entrant Mayzent, explains the analyst. Further, Raymond notes that while prior surveys have indicated a plateauing of Roche's (RHHBY) Ocrevus with Biogen's Tysabri "hanging in there," the most recent indications are for an accelerating Ocrevus with Tysabri the "clear loser." The analyst lowered his estimates for both Tecfidera and Tysabri and downgraded Biogen.
07/18/19
MSCO
07/18/19
NO CHANGE
MSCO
Underweight
Odds of success for Biogen anti-tau agent appear low, says Morgan Stanley
Morgan Stanley analyst Matthew Harrison noted that Phase IIb data from Biogen's anti-tau antibody BIIB092 in progressive supranuclear palsy, or PSP, are due in the second half of the year and could be a significant catalyst for the stock. With a clear efficacy signal, he believes the stock could be up as much as 10%-20%, while a failed study would likely drive the stock down only 1%-3% given the low expectations for success. He also notes several of his own concerns that keep his expectations low, but Harrison did point out that a potential positive result puts his Underweight thesis at risk given that there are no disease modifying therapies for PSP and having a drug to market could potentially mean a multi-billion dollar opportunity for Biogen.
06/28/19
06/28/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. 1. Walgreens Boots Alliance (WBA) downgraded to Neutral from Outperform at Credit Suisse with analyst A.J. Rice saying Walgreens cut its guidance for FY19 and reduced its long-term EPS growth target to the mid-to-high single digits and said he would want to see clear indications that visibility on earnings growth is improving before considering raising his rating. 2. Biogen (BIIB) downgraded to Neutral from Overweight at Piper Jaffray with analyst Christopher Raymond saying Piper's new neurologist survey data from Spherix Global Insights "spells bad news for both Tecfidera and Tysabri in the near and longer term." 3. Live Nation (LYV) downgraded to Sell from Neutral at Citi with analyst Jason Bazinet saying he still likes the company's growth prospects and "consistent" operating performance. 4. Arrowhead (ARWR) downgraded to Neutral from Overweight at Cantor Fitzgerald with analyst Elemer Piros saying he views the stock as fairly valued. 5. Darden (DRI) downgraded to Equal Weight from Overweight at Stephens with analyst Will Slabaugh citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/05/19
STPT
06/05/19
UPGRADE
STPT
Buy
Biogen upgraded to Buy from Hold at Standpoint Research
SHW Sherwin-Williams
$454.62

-1.9 (-0.42%)

07/12/19
SBSH
07/12/19
DOWNGRADE
SBSH
Neutral
Chemours downgraded to Neutral from Buy at Citi
Citi analyst P.J. Juvekar downgraded Chemours (CC) to Neutral from Buy saying he's turned more cautious on ethylene and TiO2. With three new ethylene crackers in the second half of 2019 and falling raw materials, the risk to polyethylene prices is to the downside, Juvekar tells investors in a research note. He prefers "more defensive names with strong balance sheets," such as Linde plc (LIN), Sherwin-Williams (SHW) and Nutrien (NTR).
06/20/19
DBAB
06/20/19
NO CHANGE
Target $35
DBAB
Buy
Axalta sale in mid-$30s per share most likely outcome, says Deutsche Bank
Deutsche Bank analyst David Begleiter raised his price target for Axalta Coating Systems (AXTA) to $35 from $30 after the company announced that its board had initiated a review of strategic alternatives, including a potential sale. The analyst views the announcement as a "solid positive," though he notes that it is not new information as Axalta has "arguably" been for sale for the last two-plus years. Further, the timing is unusual as the three most likely bidders for Axalta are somewhat constrained in the near-term as Nippon Paint is buying Dulux, AkzoNobel (AKZOY) is focused on delivering "aggressive" 2020 margin targets, and Sherwin-Williams (SHW) is still a bit levered post Valspar, Begleiter tells investors in a research note. Still, the analyst believes the most likely outcome of Axalta's process is a sale of the company in the mid-$30s per share. And without a sale, Begleiter believes downside in the stock is limited, creating an attractive risk/reward setup. He reiterates a Buy rating on Axalta Coating.
06/19/19
SBSH
06/19/19
NO CHANGE
SBSH
Axalta Coating under pressure to deliver on M&A, says Citi
Citi analyst P.J. Juvekar said Axalta is under increased pressure "to deliver on M&A now or risk its credibility" after the company announced it is exploring strategic options again after going through the same process in 2017. Previously the company had M&A negotiations with AkzoNobel (AKZOY) and briefly with Nippon Paints, though neither reached a deal, and this time it could approach new players like Berkshire Hathaway (BRK.A), which already owns roughly 10% of the company, or Sherwin-Williams (SHW), contends Juvekar. Axalta does not have architectural paint, which trades at high multiples compared to industrial paint, and he thinks a multiple range of 12x-13x, equating to a stock price in the mid-to-high $30 range, is possible in a deal, though "there is no guarantee that a deal would happen," Juvekar stated in a note to investor before the open.
06/25/19
NRCS
06/25/19
DOWNGRADE
NRCS
Neutral
Sherwin-Williams downgraded to Neutral from Buy at Northcoast
TRV Travelers
$149.95

-0.22 (-0.15%)

07/19/19
BUCK
07/19/19
DOWNGRADE
Target $158
BUCK
Neutral
Travelers downgraded to Neutral from Buy at Buckingham
Buckingham analyst Amit Kumar downgraded Travelers to Neutral from Buy with a price target of $158.
06/27/19
DBAB
06/27/19
DOWNGRADE
Target $140
DBAB
Sell
Travelers downgraded to Sell from Hold at Deutsche Bank
Deutsche Bank analyst Joshua Shanker last night downgraded Travelers to Sell from Hold with an unchanged price target of $140. The commercial Property & Casualty sector is "largely overvalued" due to an intra-sector exodus from more rate-sensitive financials into P&C insurance stocks, Shanker tells investors in a research note. Five- and 10-year interest rates have now fallen to a point where they will likely begin to have a "deleterious effect" on earnings forecasts for P&C insurers, adds the analyst.
06/27/19
06/27/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. FactSet (FDS) downgraded to Sell from Neutral at Goldman Sachs with analyst George Tong saying he believes FactSet faces "secular challenges" in the financial services end-market due to the implementation of MiFID II and the ongoing shift from active to passive asset management. 2. Travelers (TRV) downgraded to Sell from Hold at Deutsche Bank with analyst Joshua Shanker saying the commercial Property & Casualty sector is "largely overvalued" due to an intra-sector exodus from more rate-sensitive financials into P&C insurance stocks. 3. Sempra Energy (SRE) downgraded to Neutral from Buy at BofA/Merrill with analyst Julien Dumoulin-Smith citing share outperformance and moderating expectations on expedited CA legislation by the July 12 deadline combined with a potential credit downgrade. 4. W. R. Berkley (WRB) downgraded to Sell from Hold at Deutsche Bank with analyst Joshua Shanker saying investors are mistaking the appreciation in Property and Casualty insurance stocks as the "fruit of renewal rate pricing increases in the P&C market." 5. Ross Stores (ROST) and Nordstrom (JWN) downgraded to Sell from Neutral at Goldman Sachs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/19/19
BUCK
07/19/19
NO CHANGE
BUCK
Buckingham upgrades Axis Capital, downgrades Arch, Travelers ahead of earnings
As previously reported, Buckingham analyst Amit Kumar upgraded Axis Capital (AXS) to Buy from Neutral and downgraded Arch Capital (ACGL) and Travelers (TRV), both to Neutral from Buy, ahead of Q2 earnings for the insurance/reinsurance space. He believes that Axis' relative discount is no longer justified given positive pricing commentary in reinsurance and E&S markets and his analysis of reserves and he thinks the stock is best positioned to catch up to its peer group, Kumar said in his sector preview note. He raised his price target on Axis shares to $70 from $60. Arch currently trades above its 5 year average multiple to next twelve months consensus book value and he feels the stock is fully priced, said Kumar, who keeps a $38 price target on the stock. In terms of Travelers, Kumar also cites valuation and recommends that investors rotate into Hartford Financial (HIG) given its valuation discount and the fact that it should also benefit from rate increases.
PCAR Paccar
$69.17

-0.16 (-0.23%)

06/19/19
JPMS
06/19/19
NO CHANGE
JPMS
Truck stocks likely to be down on final May data, says JPMorgan
ACT Research yesterday released final truck data for May, and North America Class 8 retail sales were 29,278 units, up 17% year-over-year and up 1% month-over-month, JPMorgan analyst Ann Duignan tells investors in a research note. Builds were 31,519 units in the month, up 32% year-over-year and up 2% month-over-month, while the cancellation rate increased sharply to 22.8% in May, adds the analyst. She thinks the stocks in the truck group will likely be down on the data. Truck orders have the largest incremental impact on Navistar (NAV), Paccar (PCAR), Cummins (CMI), Eaton (ETN), Wabco (WBC) and Allison Transmission (ALSN), according to Duignan.
07/02/19
LOOP
07/02/19
DOWNGRADE
Target $62
LOOP
Sell
Paccar downgraded to Sell from Hold at Loop Capital
Loop Capital analyst Jeffrey Kauffman downgraded PACCAR to Sell from Hold and lowered his price target on the shares to $62 from $70.
07/02/19
JPMS
07/02/19
NO CHANGE
JPMS
June Class 8 truck orders drop 69% year-over-year, says JPMorgan
According to ACT Research, Class 8 net orders in June were 13,000 units, down 69% year-over-year, JPMorgan analyst Ann Duignan tells investors in a research note. The analyst points out that truck orders have the largest incremental impact on Navistar (NAV), Paccar (PCAR), Cummins (CMI), Eaton (ETN), Wabco (WBC) and Allison Transmission (ALSN).
07/02/19
LOOP
07/02/19
DOWNGRADE
Target $62
LOOP
Sell
Paccar downgraded to Sell at Loop Capital on lower economic outlook
Loop Capital analyst downgraded Paccar to to Sell from Hold and lowered his price target on the shares to $62 from $70. In a research note to investors, Kaufman says that despite more positive headlines on trade this past weekend, he continues to see a broader-based deterioration in the level of activity across key global economies and the U.S. economy, leading to continued high inventories across multiple industries. The net impact of this has bee broadening out in levels of weaker demand for both rail and truck traffic, the result of slower industrial production, and creates a more problematic outlook.
CNC Centene
$52.19

-0.46 (-0.87%)

06/17/19
06/17/19
NO CHANGE

Centene growth undervalued, political risks overdone, says Piper Jaffray
Centene's valuation multiple has compressed from 17 times to 11 times on healthcare reform risk that has little chance of coming to fruition, Piper Jaffray analyst Sarah James tells investors in a research note. The analyst believes the core Centene business has potential for long-term annual earnings growth in the 20% range. She believes the company's growth is being undervalued while political risks are overdone. The analyst calls Centene a top pick and keeps an Overweight rating on the name with an $80 price target.
07/18/19
SPHN
07/18/19
NO CHANGE
SPHN
Overweight
Iowa Medicaid MCO rate bump positive for Anthem, Centene, says Stephens
Stephens analyst Scott Fidel noted that Iowa agreed to an 8.6% rate increase in Medicaid MCO for the new fiscal year starting on July 1, calling the news a positive for Centene (CNC), which just began Medicaid operations in the state, and for incumbent Anthem (ANTM). Fidel, who thinks the rate increase should help improve margins for Anthem in Iowa and increase confidence in Centene's ability to achieve its initial targets there, keeps Overweight ratings on both stocks.
07/10/19
SPHN
07/10/19
NO CHANGE
SPHN
Overweight
Centene 'a clear winner' in Oregon Managed Medicaid awards, says Stephens
Stephens analyst Scott Fidel noted that Oregon announced awards for the state's $6B managed Medicaid program, calling Centene "a clear winner" as it retained Lane county, where it maintains essentially all of its current 88,000 Medicaid members in the state, and added three other counties that serve 36% of the state's current managed Medicaid membership. Fidel, who notes the new contracts are expected to begin on Jan. 1, 2020, keeps an Overweight rating on Centene shares.
06/25/19
SBSH
06/25/19
NO CHANGE
SBSH
Molina, Centene have most at stake from Texas Medicaid awards, says Citi
Citi analyst Ralph Giacobbe noted that Texas' "highly anticipated" STAR+PLUS contract for the states' higher acuity Medicaid members is expected to be awarded this Friday, June 28. Among the incumbents in the state, Molina (MOH) and Centene (CNC) have the most at stake, as their respective STAR+PLUS earnings contribute about 7% and 2%, respectively, of his and consensus estimates, Giacobbe tells investors. He estimates that the other incumbents - Anthem (ANTM), Cigna (CI) and UnitedHealth (UNH) - have 1% or less of their earnings at stake, adding that investor expectations are for the incumbents to largely retain business.
SWK Stanley Black & Decker
$141.45

-2.01 (-1.40%)

06/21/19
BOFA
06/21/19
INITIATION
Target $140
BOFA
Underperform
Stanley Black & Decker initiated with an Underperform at BofA/Merrill
BofA/Merrill analyst Ross Gilardi initiated Stanley Black & Decker with an Underweight and $140 price target citing slowing power tool trends, a challenging Auto segment, structural headwinds in Security, and China supply chain exposure. Gilardi said home values are slowing which has historically led to slower power tool demand, and notes the Industrial business has had negative comps in Q1 and is not likely to do much better for the next 1-2 years due to challenges in Auto. Further, the analyst does not believe the Security business will be easy to fix and said selling it is not a simple option either.
07/10/19
DBAB
07/10/19
NO CHANGE
DBAB
Deutsche says buy Stanley, sell Illinois Tool Works and Parker-Hannifin into Q2
Deutsche Bank analyst Nicole DeBlase placed a "Catalyst Call" buy on Stanley Black & Decker (SWK) along with "Catalyst Call" sells on both Illinois Tool Works (ITW) and Parker-Hannifin (PH) into the Q2 reporting season. She believes expectations are low for Stanley going into the print but sees downside to estimates for Illinois Tool Works and Parker-Hannifin.
05/21/19
05/21/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Kroger (KR) upgraded to Outperform from Market Perform at Bernstein with analyst Brandon Fletcher saying its market valuation has had a tough start this year and that he believes it is at a level where short-term and long-term capabilities are not being completely factored in. 2. TripAdvisor (TRIP) upgraded to Buy from Hold at Needham and to Neutral from Sell at Guggenheim. 3. Stanley Black & Decker (SWK) upgraded to Buy from Hold at Zelman. 4. Deckers Brands (DECK) upgraded to Buy from Neutral at BofA/Merrill with analyst Rafe Jadrosich saying he sees upside to the consensus EPS view given the strength of the Hoka brand and the company's stock buybacks. 5. Just Energy (JE) upgraded to Speculative Buy from Hold at Canaccord. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/21/19
ZELM
05/21/19
UPGRADE
ZELM
Buy
Stanley Black & Decker upgraded to Buy from Hold at Zelman
FITB Fifth Third
$27.84

-0.11 (-0.39%)

07/12/19
SBSH
07/12/19
DOWNGRADE
SBSH
Neutral
Fifth Third downgraded to Neutral from Buy at Citi
Citi analyst Keith Horowitz downgraded Fifth Third Bancorp to Neutral from Buy.
07/12/19
SBSH
07/12/19
NO CHANGE
SBSH
Morgan Stanley upgrade, Wells downgrade among Citi's bank changes
Citi analyst Keith Horowitz made seven rating changes in the U.S. Banks space after updating his estimates and target prices for a new base case rate forecast that more closely reflects the forward curve. This includes two interest rate cuts in 2019 and 2020. The analyst's terminal yield curve assumptions to Fed Funds is 1.75%. The lower rate assumptions led him to lower his normal return on tangible equity estimates ~100 basis points on average. Following these changes, Horowitz upgraded Morgan Stanley (MS) to Buy from Neutral), downgraded Comerica (CMA), Northern Trust (NTRS), and M&T Bank (MTB) to Sell from Neutral, and downgraded Wells Fargo (WFC), Citizens Financial (CFG), and Fifth Third (FITB) to Neutral from Buy.
04/17/19
JEFF
04/17/19
DOWNGRADE
Target $84
JEFF
Hold
Comerica downgraded to Hold from Buy at Jefferies
Jefferies analyst Kenneth Usdin downgraded Comerica (CMA) to Hold from Buy with an unchanged price target of $84. Following negative earnings revisions post the company's Q1 results, the analyst does not see enough upside to warrant a Buy rating. Comerica's net interest income outlook is "proving even more challenging," with another deposit cost increase in March weighing most on forward estimates, Usdin tells investors in a research note. He prefers putting new money to work into Fifth Third Bancorp (FITB) for exposure to the regional banks.
04/25/19
BMOC
04/25/19
NO CHANGE
Target $33
BMOC
Market Perform
Fifth Third price target raised to $33 from $30 at BMO Capital
BMO Capital analyst Lana Chan raised her price target on Fifth Third to $33 after its "revenue-driven" Q1 earnings beat and better than expected balance sheet growth. The analyst is keeping her Market Perform rating on the stock, saying its discount valuation relative to its regional bank peers is warranted by the "uncertainty" around the company's ability to achieve its 2020 targets.
KEY KeyCorp
$17.37

-0.08 (-0.46%)

05/06/19
JEFF
05/06/19
NO CHANGE
Target $20
JEFF
Buy
KeyCorp price target raised to $20 from $18.50 at Jefferies
Jefferies analyst Ken Usdin raised his price target for KeyCorp to $20 from $18.50 after traveling with CEO Beth Mooney and CFO Don Kimble. The analyst finds the stock's valuation attractive at nine times 2020 earnings estimates. He looks for a "stronger" Q2 and better estimate stability, especially given the company's $1B share buyback plan. Usdin keeps a Buy rating on KeyCorp.
06/21/19
BARD
06/21/19
UPGRADE
Target $19
BARD
Outperform
KeyCorp upgraded to Outperform from Neutral at Baird
Baird analyst David George upgraded KeyCorp to Outperform from Neutral and raised his price target for the shares to $19 from $18.
04/04/19
JPMS
04/04/19
NO CHANGE
JPMS
JPMorgan downgrades Comerica, Zions and KeyCorp, upgrades Signature Bank
In an attempt to reduce interest rate "sensitivity," JPMorgan analyst Steven Alexopoulos downgraded Comerica (CMA), Zions Bancorp (ZION) and KeyCorp (KEY) to Neutral from Overweight and upgraded Signature Bank (SBNY) to Overweight from Neutral. The analyst says his bearish call on the bank sector "remains fully intact" even though the stock are "technically now much cheaper" since his October 2018 call. The tailwinds that helped bottom line growth for banks over the past several years will "fully start transitioning into headwinds" during 2019, Alexopoulos tells investors in a research note. He suggests repositioning portfolios away from asset sensitive banks while simultaneously increasing exposure to liability sensitive banks.
04/04/19
JPMS
04/04/19
DOWNGRADE
Target $17
JPMS
Neutral
KeyCorp downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Steven Alexopoulos downgraded KeyCorp to Neutral from Overweight and lowered his price target for the shares to $17 from $18.
TRU TransUnion
$74.91

-0.14 (-0.19%)

11/30/18
LEHM
11/30/18
UPGRADE
Target $225
LEHM
Overweight
Barclays upgrades Fair Isaac to Overweight following recent pullback
Barclays analyst Manav Patnaik upgraded Fair Isaac (FICO) to Overweight from Equal Weight and raised his price target for the shares to $225 from $200. The analyst says his constructive view on the stock comes on the back of the recent pullback as well as his appreciation of the company's evolution as a Software name. Patnaik prefers shares of Fair Isaac and TransUnion (TRU) over Equifax (EFX) and Dun & Bradstreet (DNB).
04/24/19
BARD
04/24/19
NO CHANGE
Target $78
BARD
Outperform
TransUnion still a top idea despite 'modestly disappointing' Q1, says Baird
Baird analyst Jeffrey Meuler said TransUnion's Q1 results were "modestly disappointing, but not thesis changing" and the stock remains his top information solutions idea given that he expects accelerating growth in the near-term and sustained strong growth at attractive economics over the long-term. Despite the Q1 results, strong bookings trends, improved trends in shorter-cycle/batch revenue in March/April relative to January/February and a more favorable mortgage market outlook are among the factors he points to that give him confidence in a reacceleration. Meuler keeps an Outperform rating on TransUnion shares and raised his price target on the stock to $78 from $75.
12/07/18
FBCO
12/07/18
INITIATION
Target $70
FBCO
Neutral
TransUnion initiated with a Neutral at Credit Suisse
Target $70.
03/15/19
EXAN
03/15/19
INITIATION
Target $66
EXAN
Neutral
TransUnion initiated with a Neutral at Exane BNP Paribas
Exane BNP Paribas initiated TransUnion with a Neutral and $66 price target.
HAS Hasbro
$108.54

0.85 (0.79%)

06/18/19
JEFF
06/18/19
NO CHANGE
Target $120
JEFF
Buy
Jefferies confident in Hasbro's ability to unlock share value
After meeting with the management team, Jefferies analyst Stephanie Wissink has "increased confidence in a directional trackline toward meaningful equity value creation" for Hasbro. This will come from doubling the Wizards gaming business over the next five years, diversifying risk over time, and taking advantage of near-term share opportunities, Wissink tells investors in a research note. The analyst keeps a Buy rating on Hasbro shares with a $120 price target.
07/17/19
MKMP
07/17/19
NO CHANGE
Target $123
MKMP
Buy
Hasbro price target raised to $123 from $112 at MKM Partners
MKM Partners analyst Eric Handler raised his price target on Hasbro to $123 and kept his Buy ahead of its earnings next week, also raising his Q2 EPS view by 4c to 46c and citing a more "healthy" U.S. retail sales environment along with the company's solid product lineup. The analyst believes that Hasbro has benefited from its Marvel and Transformers along with Baby Alive products while also generating a rising contribution from Magic The Gathering. Handler adds that Marvel is well positioned longer term to sustain its revenue recovery with new product lines and segments that include Power Rangers, videogames, and the optionality with its movie strategy.
04/25/19
ARGS
04/25/19
DOWNGRADE
ARGS
Hold
Hasbro downgraded to Hold from Buy at Argus
Argus analyst John Staszak downgraded Hasbro to Hold while also lowering his FY19 and FY20 EPS outlook by 10c to $4.40 and $5.00 respectively. The analyst believes that it will be "difficult" for the company to recover revenue lost from the Toys "R" Us bankruptcy, also pointing to rising costs related to new product launches. At 22.9-times his expected FY19 earnings, Staszak sees Hasbro stock as "fully valued" and above the 18-times multiple for "other leisure products companies."
06/12/19
JEFF
06/12/19
NO CHANGE
Target $12
JEFF
Hold
Unclear if reported MGA bid is premium for Mattel, says Jefferies
The "loose" offer for Mattel by MGA Entertainment, according to press reports, was creatively constructed to bind the two entities using MGA's estimated $400M-plus in EBITDA with forgiveness of a multi-hundred million dollar lawsuit between the companies as equity, Jefferies analyst Stephanie Wissink told investors earlier in a research note. It is not clear that the implied post-deal value is a premium to current Mattel shareholders, added the analyst, who admits she's "largely indifferent" to the stock at $11. The analyst keeps a Hold rating on the name. Mattel (MAT) in morning trading is up 8% to $11.63. Its peer Hasbro (HAS) is up 61c to $106.29.
DGX Quest Diagnostics
$98.07

-1.175 (-1.18%)

07/15/19
ROTH
07/15/19
NO CHANGE
Target $7.5
ROTH
Buy
Sharecare liquidity event would help capitalize Remark AI business, says Roth Capital
Roth Capital analyst Darren Aftahi notes that privately-held Sharecare, which he estimates Remark Holdings (MARK) owns about 4.5% of, recently announced Quest Diagnostics (DGX) as its preferred laboratory partner, with Quest also making a strategic investment in the company. The analyst believes this could set the stage for a potential IPO going forward. Based on his current analysis, Aftahi thinks Remark's stake is worth about $150M-$175M, implying about $3.65-$4.31/share, multiples of its current $43M value. A liquidity event in Sharecare would help to much better capitalize Remark's AI business, he contends. The analyst reiterates a Buy rating and $7.50 price target on Remark's shares.
07/15/19
GSCO
07/15/19
DOWNGRADE
Target $85
GSCO
Sell
Goldman Sachs downgrades Quest Diagnostics to Sell, cuts target to $85
Goldman Sachs analyst Patrick Donnelly downgraded Quest Diagnostics (DGX) to Sell from Neutral and lowered his price target for the shares to $85 from $90. The company remains in a flat- to low-single-digit organic growth environment which will constrain operating profit and free cash flow growth, Donnelly tells investors in a research note. Further, the analyst sees "little reason for optimism" in the near term around the UnitedHealth (UNH) Preferred Lab Network. The incentive structure to further narrow lab use is uncertain and "in-network" status is most likely to continue to dominate volume flow, says Donnelly. He sees downside risk to Quest's to out-year estimates "as the lab business struggles to grow organically."
07/15/19
GSCO
07/15/19
DOWNGRADE
Target $85
GSCO
Sell
Quest Diagnostics downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Patrick Donnelly downgraded Quest Diagnostics to Sell from Neutral and lowered his price target for the shares to $85 from $90. The analyst sees a "challenging" setup for the shares amid "muted" Preferred Lab Network prospects.
06/25/19
DBAB
06/25/19
NO CHANGE
DBAB
Deutsche says presidential order potential long-term positive for national labs
Deutsche Bank analyst Dan Leonard said he believes the presidential executive order mandating greater healthcare price transparency could be potentially neutral in the short-term and "slightly positive" in the long-term for the national labs, LabCorp (LH) and Quest Diagnostics (DGX). He keeps a Buy rating on LabCorp and Hold rating on Quest shares.
LW Lamb Weston
$67.58

-0.98 (-1.43%)

06/19/19
GSCO
06/19/19
UPGRADE
Target $76
GSCO
Buy
Lamb Weston upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Adam Samuelson upgraded Lamb Weston to Buy from Neutral with a $76 price target. The analyst believes concerns over potato capacity are overdone.
06/19/19
GSCO
06/19/19
UPGRADE
Target $76
GSCO
Buy
Goldman upgrades Lamb Weston to Buy on attractive risk/reward
Goldman Sachs analyst Adam Samuelson upgraded Lamb Weston to Buy from Neutral with an unchanged price target of $76. After declining 18.6% year-to-date, the shares offer an" attractive valuation risk/reward," Samuelson tells investors in a research note. He believes concerns around growing potato industry capacity in 2019-2020 are overdone. Given a 1.3B pounds potato processing capacity increase in 2019-2020, industry capacity utilization remains greater than 95% at a low-point, Samuelson writes. He believes incumbent producers, not new entrants, are adding capacity, and that these utilization levels will not drive significant pricing/margin degradation for Lamb Weston.
06/19/19
06/19/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Lamb Weston (LW) upgraded to Buy from Neutral at Goldman Sachs with analyst Adam Samuelson saying the shares offer an "attractive valuation risk/reward," after declining 18.6% year-to-date. 2. TripAdvisor (TRIP) upgraded to Buy from Hold at SunTrust with analyst Naved Khan noting that the market valuation is placing more emphasis on the company's EBITDA multiple of the slower-growing Core business, even though its Experiences segment has generated annual growth of over 30% and now represents nearly a third of total sales. 3. Six Flags (SIX) upgraded to Outperform from Neutral at Wedbush with analyst James Hardiman stating believes that a number of potential catalysts line up nicely for the company, most notably Per-Capita spending improvements driven by the Membership 2.0 program, positive news flow from the company's international business and easy weather comparisons. 4. National CineMedia (NCMI) upgraded to Outperform from Neutral at Wedbush with analyst Michael Pachter saying he is less concerned about reserved seating driving later arrivals as the company has shown that it can recoup ad dollars elsewhere. 5. U.S. Steel (X) upgraded to Buy from Sell at Vertical Group with analyst Gordon Johnson after the company did the "unthinkable" and idled two U.S. plants and one in the EU. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/15/19
BOFA
07/15/19
NO CHANGE
Target $85
BOFA
Buy
Lamb Weston named a best SMID idea for second half at BofA/Merrill
BofA/Merrill Lynch analyst Bryan Spillane named Lamb Weston as a best small-to-mid cap idea for second half, citing his view that current industry conditions and company-specific actions support a case for at least 4% organic sales growth and 8% EPS growth over the next two years. He keeps a Buy rating and $85 price target on Lamb Weston shares.
JBLU JetBlue
$18.96

0.05 (0.26%)

06/20/19
IMPC
06/20/19
NO CHANGE
Target $26
IMPC
Outperform
JetBlue price target raised to $26 from $24 at Imperial Capital
Imperial Capital analyst Michael Derchin raised his price target for JetBlue Airways to $26 from $24 and maintains an Outperform rating on the shares. The company is on track to achieve its $2.50-$3.00 fiscal 2020 earnings per share target, despite lower consensus expectations, Derchin tells investors in a research note. He maintains an Outperform rating on JetBlue.
07/08/19
FBCO
07/08/19
UPGRADE
Target $19
FBCO
Neutral
JetBlue upgraded to Neutral from Underperform at Credit Suisse
Credit Suisse analyst Jose Caiado upgraded JetBlue to Neutral from Underperform on summer leisure strength and manageable 2020 expectations. The analyst also notes that the company continues to execute on its cost program and is on track to roll out new revenue initiatives by year end. Caiado also raised his price target on the shares to $19 from $16.
07/08/19
07/08/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. JetBlue (JBLU) upgraded to Neutral from Underperform at Credit Suisse with analyst Jose Caiado citing summer leisure strength and manageable 2020 expectations. 2. Johnson Controls (JCI) upgraded to Neutral from Underweight at JPMorgan with analyst Stephen Tusa saying the stock has "de-rated" and the company's fundamentals look more stable now relative to peers. 3. Orion Group (ORN) upgraded to Buy from Neutral at B. Riley FBR with analyst Alex Rygiel saying the recent weakness in the shares, partly due to deletion from the Russell 2000 index, was overdone. 4. Life Storage (LSI) upgraded to Outperform from Market Perform at Raymond James with analyst Jonathan Hughes saying his upgrade was driven by a more attractive valuation, managements focus on improving portfolio quality, and its relative size versus peers that allows for more impactful external growth. 5. Cabot Oil & Gas (COG) upgraded to Outperform from Market Perform at Wells Fargo with analyst Nitin Kumar saying he believes the company is more immune to oil price volatility and that it has long embraced the strategy of curtailing activity to increase shareholder capital return. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/13/19
JPMS
06/13/19
NO CHANGE
JPMS
American, Southwest raised domestic rates in last two days, says JPMorgan
JPMorgan analyst Jamie Baker said American Airlines (AAL) took a "plain vanilla" domestic fare increase of $5 one-way yesterday morning, which was followed by what looks like a system-wide increase from Hawaiian (HA) and a "substantive" Lower 48 increase from Southwest (LUV). He was not expecting another increase so soon after the industry took a broad-based domestic increase in the second week of May, noted Baker, who thinks evidence of domestic demand and potential Q2 guidance increases could reverse "recent apathy" towards the airline space. Other publicly traded airlines include Alaska Air (ALK), American Airlines (AAL), Delta Air Lines (DAL), JetBlue (JBLU), Southwest (LUV), Spirit Airlines (SAVE) and United Continental (UAL).
HOG Harley-Davidson
$34.25

-0.62 (-1.78%)

04/24/19
GSCO
04/24/19
DOWNGRADE
Target $34
GSCO
Sell
Goldman downgrades 'worst positioned' Harley-Davidson to Sell from Neutral
Goldman Sachs analyst David Tamberrino downgraded Harley-Davidson (HOG) to Sell from Neutral and lowered his price target for the shares to $34 from $37. The stock closed yesterday down 78c to $38.92. The analyst views Harley as the "worst positioned" within his Powersports coverage given its concentration in a "secularly declining" motorcycle market. The company needs to grow its customer-base through rider academies as well as incremental marketing spend, Tamberrino tells investors in a research note. Further, Harley-Davidson's new product introductions into more crowded markets will likely lower its margins. While Harley's move into smaller bikes and electrification has longer-term benefits, the strategy could hurt profitability given the requirements for incremental spend, says the analyst. Lastly, Tamberrino sees risk to Harley-Davidson Financial Services as interest rates rise. The analyst this morning also initiated coverage of Polaris Industries (PII) with a Buy rating and BRP Inc. (DOOO) with a Neutral rating.
04/24/19
04/24/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Harley-Davidson (HOG) downgraded to Sell from Neutral at Goldman Sachs with analyst David Tamberrino saying he views Harley as the "worst positioned" within his Powersports coverage given its concentration in a "secularly declining" motorcycle market. 2. TowerJazz (TSEM) downgraded to Neutral from Outperform at Credit Suisse with analyst Quang Tung Le saying to reflect ongoing weakness at the company's "key" radio frequency and power customers along with revised three- year deal extension with Panasonic, the analyst reduced his sales estimates. 3. Marriott (MAR) downgraded to In Line from Outperform at Evercore ISI with analyst Rich Hightower saying approaching Q1 earnings season, the analyst finds himself "incrementally negative" on hotel stocks overall - and even more so with respect to the C-Corps than the REITs - given the sector's substantial recent outperformance against the relevant benchmarks, coupled with no obvious shift in fundamentals over the last 60-90 days. 4. Kraft Heinz (KHC) downgraded to Underweight from Neutral at Piper Jaffray with analyst Michael Lavery saying expectations for the company's 2020 earnings are likely too high as it plans divestitures of underperforming businesses, which could be 20c-30c dilutive on a per share basis. 5. Hyatt (H) and Hilton (HLT) downgraded to Market Perform from Outperform at Wells Fargo. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/24/19
GSCO
04/24/19
DOWNGRADE
Target $34
GSCO
Sell
Harley-Davidson downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst David Tamberrino downgraded Harley-Davidson to Sell from Neutral and lowered his price target for the shares to $34 from $37.
06/04/19
NRCS
06/04/19
NO CHANGE
NRCS
Neutral
Harley-Davidson U.S. retail checks weak in May, says Northcoast
Northcoast analyst Brandon Rolle said his recent checks on Harley-Davidson for May showed continued weakness in U.S. retail despite easy comparisons and "aggressive" lending from its financing arm. Persistent weakness in U.S. retail sales has also hurt dealers' willingness to take on the company's new electric vehicles, said Rolle, who keeps a Neutral rating on Harley shares.
MDSO Medidata
$90.93

0.2 (0.22%)

06/13/19
RHCO
06/13/19
NO CHANGE
Target $92.25
RHCO
Hold
Medidata price target raised to $92.25 at SunTrust after acquisition by Dassault
SunTrust analyst Sandy Draper raised his price target on Medidata (MDSO) to $92.25 from $85 after the company confirmed its acquisition by Dassault Systemes (DASTY) at that price. The analyst believes that the price point will exclude any interested private equity firms with no other competing bids expected to materialize. Draper also does not anticipate any anti-trust challenges to the deal, keeping his Hold rating on the stock.
06/13/19
KEYB
06/13/19
DOWNGRADE
KEYB
Sector Weight
Medidata downgraded to Sector Weight from Overweight at KeyBanc
KeyBanc analyst Donald Hooker downgraded Medidata (MDSO) to Sector Weight after the company confirmed its acquisition by Dassault Systemes (DASTY).
06/12/19
PIPR
06/12/19
DOWNGRADE
Target $92.25
PIPR
Neutral
Medidata downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Sean Wieland downgraded Medidata Solutions (MDSO) to Neutral from Overweight and lowered his price target for the shares to $92.25 from $96 after the company reached an agreement to be acquired by Dassault Systemes (DASTY). The likelihood for higher bidders is low and the likelihood of deal completion is high, Wieland tells investors in a research note.
06/12/19
JPMS
06/12/19
UPGRADE
Target $92.25
JPMS
Neutral
Medidata upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Sterling Auty upgraded Medidata Solutions (MDSO) to Neutral from Underweight and raised his price target for the shares to $92.25 from $74 after the company agreed to be acquired by Dassault Systemes (DASTY).
GPK Graphic Packaging
$14.27

0.025 (0.18%)

01/04/19
UBSW
01/04/19
INITIATION
Target $12
UBSW
Neutral
Graphic Packaging initiated with a Neutral at UBS
UBS analyst Edlain Rodriguez initiated Graphic Packaging with a Neutral rating and $11.50 price target.
12/27/18
12/27/18
NO CHANGE

Stephens to keep GrubHub, RealPage, Vulcan Materials on 2019 Best Ideas list
Stephens said that it plans to publish a complete updated 2019 Best Ideas list on January 2, but in anticipation it shared the names that are being dropped and the three stocks that will remain on the list. The holdovers are GrubHub (GRUB), RealPage (RP) and Vulcan Materials (VMC). The stocks being removed include Boston Scientific (BSX), Brookdale Senior Living (BKD), Conn's (CONN), CoStar Group (CSGP), Curo Group (CURO), FedEx (FDX), First Financial Bancorp (FFBC), Graphic Packaging (GPK), Hub Group (HUBG), Keane Group (FRAC), KeyCorp (KEY), LKQ Corp. (LKQ), Myriad Genetics (MYGN), SVB Financial (SIVB), Triumph Bancorp (TBK), TrueCar (TRUE) and Union Bankshares (UBSH).
01/07/19
SBSH
01/07/19
UPGRADE
Target $27
SBSH
Buy
Silgan Holdings upgraded to Buy from Neutral at Citi
Citi analyst Anthony Pettinari upgraded Silgan Holdings (SLGN) to Buy with an unchanged price target of $27. The analyst says the upgrade reflects a more defensive positioning for Paper & Packaging in 2019. Following 2018's underperformance there are some supportive signs on valuation, with the Packagers' disconnect from Consumer Staples "especially noteworthy," Pettinari tells investors in a research note. Crown Holdings (CCK), Berry Global (BERY) and Graphic Packaging (GPK) are his top picks for 2019.
06/17/19
BARD
06/17/19
NO CHANGE
Target $17
BARD
Outperform
Graphic Packaging shares ready to break higher, says Baird
Baird analyst Ghansham Panjabi noted Graphic Packaging shares have frustrated investors for more than two years but he believes the shares are ready to break higher. He believes margin expansion, an increasingly favorable core volume outlook, and an offensive bias toward free cash flow allocation should help the shares out of their previous holding pattern. Panjabi reiterated his Outperform rating and raised his price target to $17 from $15 on Graphic Packaging shares.
AN AutoNation
$42.01

-0.045 (-0.11%)

05/06/19
MSCO
05/06/19
UPGRADE
Target $94
MSCO
Overweight
Morgan Stanley more positive on auto dealers, upgrades Group 1 to Overweight
As previously reported, Morgan Stanley analyst Armintas Sinkevicius upgraded Group 1 Automotive (GPI) to Overweight from Equal Weight as he turns positive on the traditional auto dealer group and named it his top pick among the traditional dealers. Sinkevicius sees the potential for an elongated auto cycle following changes to the Fed policy, he noted, adding that he is also drawn to the defensiveness of the dealer model and investor positioning. The analyst, who noted that his estimates are above consensus for all of the traditional dealers in Q2 and for 2019, raised his price target on Group 1 shares to $94 from $67, raised his target on Asbury Automotive (ABG) to $87 from $85, upped his target on AutoNation (AN) to $36 from $27, raised his target on Lithia Motors (LAD) to $128 from $117, increased his target on Sonic Automotive (SAH) to $18 from $10 and keeps a $56 price target on Penske Automotive (PAG).
05/31/19
LBOW
05/31/19
INITIATION
LBOW
Neutral
AutoNation initiated with a Neutral at Longbow
02/19/19
02/19/19
INITIATION

Fly Intel: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Southern Copper (SCCO) initiated with a Buy at Goldman Sachs. 2. Arcturus Therapeutics (ARCT) initiated with a Buy at Laidlaw. 3. HEXO Corp (HEXO) initiated with an Outperform at Oppenheimer. 4. Group 1 Automotive (GPI) and Lithia Motors (LAD) were initiated with an Overweight at JPMorgan, while Penske Automotive (PAG) and Asbury Automotive (ABG) were initiated with a Neutral, and Sonic Automotive (SAH) and AutoNation (AN) were initiated with an Underweight at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/30/19
RHCO
04/30/19
NO CHANGE
Target $43
RHCO
Hold
AutoNation price target raised to $43 from $38 at SunTrust
SunTrust analyst Stephanie Benjamin raised her price target on AutoNation to $43 after its Q1 earnings beat thanks to its "higher gross profit across new, used, and parts & service" sales along with lower than expected SG&A costs. The analyst is keeping her Hold rating on the company however, warning that AutoNation's brand diversification and digital investment costs may continue to weigh on profitability.

TODAY'S FREE FLY STORIES

DB

Deutsche Bank

$6.98

-0.19 (-2.65%)

, COF

Capital One

$83.06

-2.68 (-3.13%)

17:57
08/23/19
08/23
17:57
08/23/19
17:57
Periodicals
Deutsche Bank, Capital One won't say if they have Trump's tax returns, NYP says »

Deutsche Bank (DB) and…

DB

Deutsche Bank

$6.98

-0.19 (-2.65%)

COF

Capital One

$83.06

-2.68 (-3.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

MXIM

Maxim Integrated

$52.14

-2.42 (-4.44%)

17:53
08/23/19
08/23
17:53
08/23/19
17:53
Hot Stocks
Maxim Integrated's Jain sells 12,683 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

GLD

SPDR Gold Shares

$144.15

2.77 (1.96%)

17:42
08/23/19
08/23
17:42
08/23/19
17:42
Hot Stocks
SPDR Gold Shares holdings rise to 859.83MT to 854.84MT »

This is the fourth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AUMN

Golden Minerals

$0.27

0.0159 (6.38%)

17:33
08/23/19
08/23
17:33
08/23/19
17:33
Hot Stocks
Golden Minerals receives noncompliance notice from NYSE »

Golden Minerals announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DMPI

DelMar Pharmaceuticals

$0.77

0.0047 (0.61%)

17:25
08/23/19
08/23
17:25
08/23/19
17:25
Hot Stocks
Intracoastal Capital reports 9.99% passive stake in DelMar Pharmaceuticals »

Intracoastal Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTN

Raytheon

$180.58

-6.44 (-3.44%)

17:22
08/23/19
08/23
17:22
08/23/19
17:22
Hot Stocks
Raytheon awarded $534M Army contract »

Raytheon was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UHAL

Amerco

$339.43

-2.97 (-0.87%)

17:21
08/23/19
08/23
17:21
08/23/19
17:21
Hot Stocks
Amerco announces special cash dividend of 50c per share »

The dividend will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTLA

Intellia Therapeutics

$15.77

-1.08 (-6.41%)

17:20
08/23/19
08/23
17:20
08/23/19
17:20
Syndicate
Breaking Syndicate news story on Intellia Therapeutics »

Intellia Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$183.42

-4.19 (-2.23%)

17:19
08/23/19
08/23
17:19
08/23/19
17:19
Hot Stocks
General Dynamics awarded $1.08B Navy contract modification »

General Dynamics has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVLN

Novelion Therapeutics

$0.66

-0.0523 (-7.37%)

17:17
08/23/19
08/23
17:17
08/23/19
17:17
Hot Stocks
Stonepine Capital reports 6.1% passive stake in Novelion Therapeutics »

Stonepine Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$376.85

-8.91 (-2.31%)

17:14
08/23/19
08/23
17:14
08/23/19
17:14
Hot Stocks
Lockheed Martin awarded $2.43B Navy contract modification »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONCS

OncoSec

$1.84

-0.03 (-1.60%)

17:14
08/23/19
08/23
17:14
08/23/19
17:14
Syndicate
Breaking Syndicate news story on OncoSec »

OncoSec files $50M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNXP

Tonix Pharmaceuticals

$0.42

-0.0249 (-5.60%)

17:09
08/23/19
08/23
17:09
08/23/19
17:09
Syndicate
Breaking Syndicate news story on Tonix Pharmaceuticals »

Tonix Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$284.86

-7.5 (-2.57%)

17:08
08/23/19
08/23
17:08
08/23/19
17:08
General News
Trump to raises tariff rates on Chinese goods, CNBC says »

U.S. President Donald…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$284.86

-7.5 (-2.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATIS

Attis Industries

$1.03

-0.08 (-7.21%)

17:06
08/23/19
08/23
17:06
08/23/19
17:06
Hot Stocks
Attis Industries provides update on status of Nasdaq listing »

Attis Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVEO

Civeo

$1.32

-0.07 (-5.04%)

17:04
08/23/19
08/23
17:04
08/23/19
17:04
Syndicate
Breaking Syndicate news story on Civeo »

Civeo files $300M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGO

Assured Guaranty

$42.56

-1.09 (-2.50%)

16:58
08/23/19
08/23
16:58
08/23/19
16:58
Hot Stocks
Assured Guaranty CEO sells 30,300 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMED

Ra Medical Systems

$1.87

-0.055 (-2.86%)

16:50
08/23/19
08/23
16:50
08/23/19
16:50
Hot Stocks
Ra Medical Systems discloses NYSE notice related to 10-Q filing delay »

Ra Medical Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBA

Pembina Pipeline

$35.73

-0.81 (-2.22%)

16:47
08/23/19
08/23
16:47
08/23/19
16:47
Syndicate
Breaking Syndicate news story on Pembina Pipeline »

Pembina Pipeline files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

APEN

Apollo Endosurgery

$3.50

(0.00%)

16:44
08/23/19
08/23
16:44
08/23/19
16:44
Syndicate
Breaking Syndicate news story on Apollo Endosurgery »

Apollo Endosurgery files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:40
08/23/19
08/23
16:40
08/23/19
16:40
General news
Fed's Clarida said the global economy has worsened »

Fed's Clarida said…

LQDA

Liquidia Technologies

$5.23

-0.38 (-6.77%)

16:35
08/23/19
08/23
16:35
08/23/19
16:35
Syndicate
Breaking Syndicate news story on Liquidia Technologies »

Liquidia Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

V

Visa

$175.24

-4.91 (-2.73%)

16:32
08/23/19
08/23
16:32
08/23/19
16:32
Hot Stocks
Visa CFO Prabhu sells over 25,000 class A common shares »

Visa vice chairman and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 27

    Oct

QCOM

Qualcomm

$73.57

-3.55 (-4.60%)

16:31
08/23/19
08/23
16:31
08/23/19
16:31
Hot Stocks
Qualcomm CFO Dave Wise to retire, Akash Palkhiwala named interim CFO »

Qualcomm announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 06

    Nov

ANFI

Amira Nature Foods

$0.58

-0.0144 (-2.44%)

16:30
08/23/19
08/23
16:30
08/23/19
16:30
Hot Stocks
Amira Nature Foods receives NYSE notice over late Form 20-F filing »

Amira Nature Food…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.